Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Bioethics Stories

2013-11-14 23:26:48

Evidence In Motion releases Called To Care, a course that focuses on the non-clinical factors that impact patient outcomes. (PRWEB) November 14, 2013 Evidence In Motion (EIM) is pleased to announce the release of Called to Care, a program designed to shift healthcare away from deeply impersonal care towards an enhanced commitment among caretakers to high quality patient connections with an emphasis on compassion and empathy. Called to Care is based on recent research conducted by EIM...

2013-11-13 23:03:59

Preclinical Testing at Icahn School of Medicine at Mount Sinai Shows SUMO-1 Gene Therapy Shrinks an Enlarged Heart, Improves Heart Function, and Blood Flow New York, NY (PRWEB) November 13, 2013 Researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models. The new research study findings, published in November 13 issue of...

2013-11-05 12:24:46

OTTAWA, Nov. 5, 2013 /CNW/ - The Honourable Bal Gosal, Minister of State (Sport), today announced additional funding from the Government of Canada, in partnership with the Canadian Olympic Committee and the Canadian Paralympic Committee, for the Canadian Centre for Ethics in Sport in support of the Canadian Anti-Doping Program. "I am pleased to stand with our partners, the Canadian Olympic Committee and the Canadian Paralympic Committee, in the fight against doping in sport,"...

2013-11-05 10:41:44

Johns Hopkins bioethicist Nancy Kass is a guest editor of the AJPH special issue taking a comprehensive look at the current ethical landscape of human subjects research with minority populations Remarkable improvements in the quality of life, prevention and treatment of disease have been made possible through advancements in biomedical research, including clinical trials involving human subjects.  Future progress will depend in large measure on the inclusion of women and racial and ethnic...

2013-10-30 15:35:50

Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload. In a study published recently in Molecular Therapy, researchers found that giving subjects a treatment to temporarily rid the body of antibodies provides the virus safe passage to targeted cells, allowing it to release a...

2013-10-24 23:29:56

Creighton University bioethics professor, Amy Haddad, Ph.D., receives honor of being named President-Elect of the American Society of Bioethics and Humanities. Omaha, NE (PRWEB) October 24, 2013 Creighton University today announced Amy Marie Haddad, Ph.D., has been named president-elect of the American Society of Bioethics and Humanities (ASBH). Haddad is currently a Creighton University professor, the director of the Center for Health Policy and Ethics and the Dr. C.C. and Mabel L. Criss...

2013-10-24 20:22:13

Demystifies PAM compliance for AAALAC accreditation and risk mitigation FAIRFAX, Va., Oct. 24, 2013 /PRNewswire-iReach/ -- SoBran is proud to announce the release of a white paper on Post Approval Monitoring (PAM) The What, Why and How of Instituting a Professional Post-Approval Monitoring Program. IACUC (Institutional Animal Care and Use Committee) post approval monitoring implementation is required for accreditation and licensing by such agencies as AAALAC (Association for...

2013-10-23 23:24:16

Evidence in Motion Executives Write Article Published in the Journal of Orthopaedic & Sports Physical Therapy Exploring the Placebo and Nocebo Phenomena, Their Effect On Patient Outcomes, and Real World Implications Louisville, KY (PRWEB) October 23, 2013 An article and follow up responses written by Louisville physical therapist Dr. Laurence N. Benz, PT, DPT, MBA, MAAP and Ft. Collins, CO physical therapist Timothy W. Flynn, PT, PhD, for the July 2013 Journal of Orthopaedic &...

2013-10-18 23:00:43

Co-founder and President Barbara Netter thanks donors for supporting ground-breaking and life-saving research. More than 100 prominent donors, scientists, biotech representatives, and physicians attended Alliance for Cancer Gene Therapy’s “Achieving Cancer Remission with Cell and Gene Therapies” Tuesday night at the Harvard Club of New York City. New York, NY and Stamford, CT (PRWEB) October 18, 2013 More than 100 prominent donors, scientists, biotech representatives, and physicians...

2013-10-15 04:21:08

CAMBRIDGE, England, October 15, 2013 /PRNewswire/ -- Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients. The study showed that APD515 significantly reduced the symptoms of dry mouth (the primary endpoint) compared to placebo. APD515 is an optimised oromucosal (liquid) formulation of a currently...


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »